ArticleBMC infectious diseases2026

Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process.

Hyeontaek Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.